Sommaire
CLINICAL ISSUES - Sublingual immunotherapy vs subcutaneous immunotherapy. The first placebo controlled trial. Interview with Pr P. Scheinman, Paris.
SCIENTIFIC MATTERS - The allergy march explained. Interview with Pr U.Wahn, University of Berlin.
REGULATORY DOSSIER - A new regulatory setting for Named Patient Product.
DISCUSSION POINTS with Pr J. E. Rosado Pinto, about CIPP VI, Lisbon, Portugal.
PRESS REVIEW